Under Review Due in 7 days (Aug 9, 2023)

Novel Approaches to CRISPR Gene Editing in Cancer Treatment

Manuscript ID: MS-2023-0042 • Submitted to Nature Biotechnology on July 12, 2023

Authors: Lin Zhang, Sarah Johnson, David Lee, Maria Rodriguez
Institution: Stanford University
Pages: 24
Keywords: CRISPR, Gene Editing, Cancer Treatment, Oncology

Review Timeline

Invitation Accepted

Jul 18, 2023

Files Accessed

Jul 20, 2023

Review in Progress

Current Stage

Review Submitted

Due Aug 9, 2023

Evaluation
Comments to Authors
Confidential Notes
Recommendation

Manuscript Evaluation

Please rate the manuscript on the following criteria. Your evaluation will help the editors make an informed decision.

Originality and Significance

Rating:

Does the manuscript present novel findings or concepts? Is the work significant to the field?

Research Methodology

Rating:

Are the methods appropriate, well-described, and sufficiently detailed for replication?

Results and Data Analysis

Rating:

Are the results clearly presented? Is the data analysis appropriate and thorough?

Discussion and Conclusions

Rating:

Are the conclusions supported by the results? Does the discussion address the implications and limitations?

Literature and References

Rating:

Is the literature review comprehensive? Are references current and relevant?

Reviewer Resources

Journal Guidelines

Review Nature Biotechnology's specific reviewer guidelines

Review Checklist

Download a comprehensive review checklist

Reviewer Tutorial

Watch a tutorial on effective peer reviewing

FAQs

Find answers to common reviewer questions

View All Resources